Medicare Advantage Premiums Becoming Less of a Concern?
Although increases in monthly premiums for Medicare Advantage plans are becoming more of the norm, it doesn’t seem to bother
Read More
Author: Gerry Hafer
Lecanemab approval being pursued for Alzheimer’s Treatment
Japan-based pharmaceutical company Eisai Co., Ltd. recently anno0unced plans to seek full approval for its Alzheimer’s treatment drug lecanemab, a
Read MoreMemory Care Emerging Quickly in Popularity
Remember when the most popular component of Medicare Advantage plans was the addition of a gym membership? It seems lately
Read MoreAnnual Enrollment Period: Some Things to Think About
Choosing the right Medicare plan is something that requires a bit of thought, as well as careful analysis of one’s
Read MoreThe Cost of Medicare Advantage Plans Under Scrutiny
In an article titled “Medicare Advantage have overpaid by more than $100B since 2010,” Kaiser Health News analyst Fred Schulte provides
Read MoreIt’s That Time of the Year…Choosing the Right Approach to Medicare
It’s the time of the year when we’re all bombarded with ads, alerts, and non-stop commentary about the Medicare enrollment choices,
Read MorePrice-shifting Strategies Could Affect Patients’ Out-of-pocket Costs
In a post on www.reuters.com, Reuters reporter Lisa Rapaport examines proposals on the table to reduce drug spending primarily through shifting
Read MoreAmericans Express Displeasure Re:Health Care System
Gallup’s annual Healthcare poll indicates that Americans continue to their healthcare system negatively, and that this view has not radically changed
Read MoreTransparency in Healthcare…Posting of Procedure Pricing
In an article posted on www.oanow.com by reporter Timothy Noordermeer, the recent federal law enacted requiring hospitals to publicly display a list of
Read MoreRetirement Mistakes That Can Cost You
Retirement can be a stressful time for many folks, and the decisions that need to be made can be daunting.
Read More